News & Views
Collaboration Seeks to Optimise Bioproduction Cell Lines
Mar 19 2017 Comments 0
Horizon Discovery Group plc has entered into an R&D partnership and license agreement with AmplyCell S.A, to evaluate the impact of AmplyCell’s BOOST cell line optimisation technology on Horizon’s parental GS (glutamine synthetase) null CHO K1 cell line.
Under the terms of the agreement, Horizon will make an upfront payment (figure not disclosed) to AmplyCell. Upon establishing a positive impact on the CHO cell line, AmplyCell will then be entitled to receive success-based development and commercial milestone payments and Horizon will have the non-exclusive worldwide rights to sublicense these BOOSTed CHO-K1 cell lines to third parties. AmplyCell is also eligible to receive tiered royalties based on the net sales of these sublicensed lines.
Terry Pizzie, Head of Commercial, Horizon Discovery said: “We are hopeful that a successful evaluation of AmplyCell’s BOOST technology will lead to incorporation of this methodology for all future bioprocessing cell lines released by Horizon and look forward to creating a long term relationship with AmplyCell.”
Geoffrey Holsbeek, CEO of AmplyCell S.A added: “AmplyCell is delighted to enter into this collaboration with Horizon. They have already demonstrated significant success in establishing biomanufacturing licensing deals around the globe and we are pleased to be able to support their drive to remain at the forefront of cell innovation.”
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In this Issue Mass Spectrometry & Spectroscopy - 65th ASMS Conference on Mass Spectrometry and Allied Topics - Reduced injection volume applied to the quantitation of cylindrospermopsin an...
View all digital editions
Aug 21 2017 Lausanne, Switzerland
Aug 22 2017 Karachi, Pakistan
Aug 30 2017 Shanghai, China
Aug 30 2017 Lagos, Nigeria
Sep 04 2017 Birmingham, UK